Skip to main content

Abstract

Virus hepatitis is a group of systemic infectious diseases induced by various types of hepatitis virus, predominantly with liver damages. Based on the pathogen, virus hepatitis can be categorized into five types: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. Hepatitis A and hepatitis E are transmitted mainly via fecal-mouth route which are mainly manifested as acute infections. Hepatitis B, hepatitis C, and hepatitis D are transmitted mainly via extra-gastrointestinal routes, commonly manifested as chronic infection, and the condition rarely develops into hepatic cirrhosis and even hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  1. Vieth S, Manegold C, Drosten C, et al. Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany. Virus Genes. 2002;24(2):153–6.

    Article  CAS  PubMed  Google Scholar 

  2. Arauz-Ruiz P, Norder H, Robertson BH, et al. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;83(pt 8):2059–73.

    Article  CAS  PubMed  Google Scholar 

  3. Farci P, Shimoda A, Coiana A, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288(5464):339–44.

    Article  CAS  PubMed  Google Scholar 

  4. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81(pt 1):67–74.

    Article  CAS  PubMed  Google Scholar 

  5. Amarapurkar D. Role of liver biopsy in management of chronic hepatitis B and chronic hepatitis C. Trop Gastroenterol. 2007;28(2):67–8.

    PubMed  Google Scholar 

  6. Cholongitas E, Senzolo M, Standish R, et al. A systematic review of quality of liver biopsy specimens. Am J Clin Pathol. 2006;125(5):710–21.

    Article  PubMed  Google Scholar 

  7. Fiel MI. Pathology of chronic hepatitis B and chronic hepatitis C. Clin Liver Dis. 2010;14(4):555–75.

    Article  PubMed  Google Scholar 

  8. Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598–607.

    Article  PubMed  Google Scholar 

  9. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis. 2004;24(1):89–97.

    Article  PubMed  Google Scholar 

  10. Ishak KG. Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol. 2000;113(1):40–5.

    Article  CAS  PubMed  Google Scholar 

  11. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–39.

    Article  CAS  PubMed  Google Scholar 

  12. Lefkowitch JH. Advances in hepatobiliary pathology: update for 2010. Clin Liver Dis. 2010;14(4):747–62.

    Article  PubMed  Google Scholar 

  13. Tsuang W, Subramanian R, Liu Q, et al. The need for liver biopsy in a patient with acute HCV infection. Nat Clin Pract Gastroenterol Hepatol. 2008;5(1):54–7.

    Article  PubMed  Google Scholar 

  14. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130(3):678–86.

    Article  PubMed  Google Scholar 

  15. Arase Y, Suzuki F, Suzuki Y, et al. Sustained virology response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology. 2009;49(3):739–44.

    Article  CAS  PubMed  Google Scholar 

  16. Buster EH, Flink HJ, Cakaloglu Y, et al. Sustained HbeAg and HBsAg loss after long-term follow-up of HbeAg positive patients treated with peginterferon alpha-2b. Gastroenterology. 2008;135(2):459–67.

    Article  CAS  PubMed  Google Scholar 

  17. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34(6):1225–41.

    Article  CAS  PubMed  Google Scholar 

  18. Kim HC, Yang DM, Jin W. The various manifestations of ruptured hepatocellular carcinoma: CT imaging finding. Abdom Imaging. 2008;33(6):633–42.

    Article  PubMed  Google Scholar 

  19. Xu PJ, Yan FH, Wang JH, et al. Added value of breath hold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging. 2009;29(2):341–9.

    Article  PubMed  Google Scholar 

  20. Kim YK, Han YM, Kim CS. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol. 2009;70(1):94–100.

    Article  PubMed  Google Scholar 

  21. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4(8):936–62.

    Article  CAS  PubMed  Google Scholar 

  22. Marcellin P, Chang TT, Lim SG, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2008;48(3):750–8.

    Article  CAS  PubMed  Google Scholar 

  23. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006;131(6):1743–51.

    Article  CAS  PubMed  Google Scholar 

  24. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med. 2003;348(9):800–7.

    Article  CAS  PubMed  Google Scholar 

  25. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354(10):1001–10.

    Article  CAS  PubMed  Google Scholar 

  26. Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354(10):1011–20.

    Article  CAS  PubMed  Google Scholar 

  27. Liaw YF, Gane E, Leung N, et al. 2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology. 2009;136(2):486–95.

    Article  CAS  PubMed  Google Scholar 

  28. Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007;357(25):2576–88.

    Article  CAS  PubMed  Google Scholar 

  29. Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359(23):2442–55.

    Article  CAS  PubMed  Google Scholar 

  30. Ghany MG, Nelson DR, Strader DB, et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(4):1433–44.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Chen YC, Chu CM, Yeh CT, et al. Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study. Hepatol Int. 2007;1(1):267–73.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Yang Gen-dong, Lu Pu-xuan, Zhou Bo-ping, et al. Hemochromatosis with excessive iron deposition in the liver: report of 1 case. Chin J Hepatol. 2006;8(14):634.

    Google Scholar 

  33. Wang Cheng-lin, Zhou Kang-rong. CT and MRI diagnosis of hepatopathy. Beijing: People’s Health Publishing House; 2007.

    Google Scholar 

  34. Zhou Bo-ping, Chong Yu-tian. Viral hepatitis. Beijing: People’s Health Publishing House; 2011.

    Google Scholar 

  35. Lang Zhen-wei. Hepatocytic apoptosis and pathology of viral hepatitis. Chin J Hepatol. 1999;7:116.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wu Shi-Pin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht and People's Medical Publishing House

About this chapter

Cite this chapter

Shi-Pin, W. et al. (2016). Viral Hepatitis. In: Lu, PX., Zhou, BP. (eds) Diagnostic Imaging of Emerging Infectious Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7363-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7363-8_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7362-1

  • Online ISBN: 978-94-017-7363-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics